G0452 Molecular pathology interprMolecular pathology procedure; physician interpretation and report
Status A: active, paid separately under the PFS if covered. Global period XXX. Qualifying APM participants are paid at a $33.5675 conversion factor.
1 of 1 payer prior-auth lists that name G0452 require prior authorization or set conditions: Blue Cross Blue Shield of Arizona (AZ Blue).
| Payer | Plan | State | Prior auth | Conditions | Since | Source |
|---|---|---|---|---|---|---|
| Blue Cross Blue Shield of Arizona (AZ Blue) | Federal Employee Program (FEP) | AZ | prior auth required | Sep 1, 2026 | Federal Employee Program (FEP) Prior Authorization Requirements Code List (Updated 09/01/2026) |
G0452 appears in 2 coverage policies from Blue Cross & Blue Shield of Mississippi, Blue Shield of California.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Blue Cross & Blue Shield of Mississippi | Genetic Testing (L.2.04.409) | covered if criteria are met | payer document | |
| Blue Shield of California | Genetic Testing for Predisposition to Inherited Hypertrophic Cardiomyopathy (2.02.28) | listed, no stance | payer document |
Prior authorization required or conditional in IN.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.